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Abstract  
As UNAIDS 90-90-90 targets for people living with HIV are increasingly being reached in 
many contexts, health-related quality of life (HRQoL), the ”fourth 90”, warrants special 
attention. HIV-related stigma and discrimination remain major barriers for overall HRQoL 
despite impressive clinical and virological improvements in HIV care. We reviewed original 
publications examining the impact of interventions to reduce stigma as experienced by people 
living with HIV in all income settings between 2010-2018. Our search identified a lack of well-
designed intervention studies that documented stigma reduction and few studies that 
specifically assessed the impact of stigma on HRQoL. Further, few interventions targeted 
discrimination from providers outside HIV-specific care or involved people living with HIV in 
both the design and implementation. Lastly, evidence on methods to reduce stigma among 
several underrepresented key populations and geographic regions was limited and research on 
intersectional stigma, i.e. the convergence of multiple stigmatized identities, needs further 
attention.   
 
Keywords: Review, HIV, fourth 90, stigma, discrimination, intervention, quality of life, health- 
related quality of life, non-communicable diseases, mental well-being, intersectional stigma 
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Key Message Panel  
 
 HIV-related stigma and discrimination remain major obstacles for reaching good health-related 
quality of life (HRQoL). 
 Despite considerable efforts to combat HIV-related stigma and discrimination, the effects 
experienced by people living with HIV are insufficiently evaluated and documented. 
 There is a lack of well-designed intervention studies that document stigma reduction. 
 Few interventions specifically assessed the impact of HIV stigma on HRQoL 
 Few interventions involved people living with HIV in either the design or implementation, although 
the existing evidence shows the importance of this for relevant and sustainable impact 
 Evidence remains scarce on methods to reduce HIV stigma among several key populations and in 
many geographic regions.  
 Further research is required on how to address intersectional stigma for populations 
disproportionally affected by HIV, and on how to prevent discrimination from healthcare providers 
outside HIV-specific care, a growing concern to reach the 4th 90 as it undermines health seeking for 
mental health disorders and other comorbidities. 
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Introduction  
  
With effective antiretroviral therapy delivering high levels of sustained virological suppression, 
health-related quality of life (HRQoL) among people living with HIV warrants special 
attention. The UNAIDS 90-90-90 targets for epidemic control (i.e. that by 2020, 90% of all 
people living with HIV will know their status, 90% of people diagnosed with HIV infection 
will receive sustained antiretroviral therapy (ART), and 90% of those receiving ART will be 
virally suppressed) are increasingly being reached in many contexts.1,2 However, these “three 
90s” do not account for many remaining concurrent challenges among people living and ageing 
with HIV  who still experience suboptimal HRQoL with regards to their mental, sexual and 
physical well-being.2 
 
The addition of a “fourth 90” that includes improved HRQoL for people living with HIV 
requires solutions that go beyond ART and viral suppression. Impressive clinical and 
virological progress over the past two decades has resulted in significant advancements in both 
clinical treatment outcomes and HIV prevention options. Today, convincing evidence that the 
risk of HIV transmission approaches negligible levels when people are virally suppressed on 
ART has revolutionized public health communication related to the risk of HIV transmission.3 
Stigma, however, can negatively impact the happiness, self-esteem, sexual and social 
relationships and the sense of purpose among those living with HIV.4 Previous research has 
shown that HIV-related stigma and discrimination are strongly associated with self-assessed 
overall quality of life (QoL) and mental well-being.5-13 Fear of stigma and discrimination can 
also inhibit health seeking behaviour and is a major obstacle for timely diagnosis14, prevention 
efforts15,16 and linkage to care and support17-19 not only for HIV, but also for mental health 
disorders and other concurrent conditions, many of which are  associated with ageing with HIV. 
HIV associated stigma remains a major human rights challenge and addressing HIV-related 
stigma and discrimination will be necessary to achieve the goal of ending AIDS as a public 
health threat by 2030.20  
 
Stigma  
Goffman’s often cited definition of stigma describes it as “an attribute that is deeply 
discrediting, that reduces the bearer from a whole person to a tainted, discounted one”.21 More 
recently, it has been argued that stigma is constructed by a variety of psychological and societal 
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factors, and “…exists when elements of labelling, stereotyping, separating, status loss and 
discrimination co-occur in a power situation that allows the process to unfold”.22 
 
HIV associated stigma is closely related to societal power structures, legal frameworks, and 
intersecting prejudices experienced by many of the sub-populations disproportionally affected 
by HIV.23 It may serve a human need to categorize things and to “hold social structures in place, 
maintain boundaries and inequalities between groups of people and between those who have 
power and those who do not” (see Box 1 for an expanded description of the process of 
stigma).24,25 People living with HIV often encounter intersectional stigmas, i.e. the convergence 
of multiple stigmatized identities due to intersecting prejudices related to affiliations to 
marginalized groups such as ethnic identity, sexual orientation, gender, or moralizing societal 
views attributed to certain characters or behaviours such as substance use, sex work, poverty or 
incarceration.26 Turan et al. recommended researchers to avoid over-simplified categorization 
and to analyze multiple identities in greater depth in order to increase evidence for interventions 
that target intersectional stigmas.26 Earnshaw and colleagues designed the HIV Stigma 
Framework, validated with empirical data, which clearly outlines mechanisms and 
consequences for stigma for HIV prevention and intervention.27 Birbeck and colleagues build 
on this framework recognizing the drivers, manifestations and outcomes of health-related 
stigma and discrimination that cut across disease contexts, enabling a more unified approach, 
beyond individual conditions, that could guide future stigma reduction interventions.28 
Similarly, Stangl et al. recently proposed a cross-cutting theoretical “Health Stigma and 
Discrimination framework” that could be applied across a range of stigmatizing health 
conditions, including HIV, while also accounting for intersectional stigma.29  
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Box 1. Description of the Process of Stigma23 
 
At an individual level, stigmatization in the form of prejudices and negative attitudes towards 
people living with HIV can materialize into discriminatory actions, such as job or housing 
refusal or social exclusion at the workplace, in school or in other social environments.22 
Structural discrimination due to HIV stigma includes physical and social structures that inhibit 
or limit people living with HIV from equal opportunities to obtain employment, work or 
residence permits, to get married, to travel, or being denied parental rights such as assisted 
fertilisation or adoption.22,30 Recently, UNAIDS formed a global partnership for action aiming 
to eliminate all forms of HIV stigma and discrimination, recognizing the importance of 
addressing the multiple stigmatizing experiences (intersectional stigmas) of key populations, 
such as sex workers, people who inject drugs, men who have sex with men (MSM), transgender 
people, people in prisons and other closed settings and, in some social contexts, women, young 
people, migrants, refugees and internally displaced people.20  
 
Stigma Reduction Interventions and Health-Related Quality of Life (HRQoL) 
Working towards improved HRQoL and the ”fourth 90” requires validated tools to monitor 
long-term progress as well as targeted interventions to reduce the stigma experienced among 
people living with HIV. We also need to better understand which stigma reducing interventions 
to invest in beyond the healthcare setting since HIV-related stigma and discrimination may 
occur in every area of social life and at multiple levels, including inside families, communities, 
schools and workplaces and within the justice system.20  In 2014, UNAIDS published a 
resource-kit for high-impact stigma reduction programming, stating that “every national 
response should be based on an evidence-informed understanding of HIV-related stigma”.31 
Stigma drivers: individual-level factors that may originate from lack of knowledge of HIV, 
prejudices and use of stereotypes and cognitive processes which help us to make sense of the 
world 
Stigma facilitators: societal-level factors that maintain stigma including laws and regulations, 
cultural and gender norms and economic status 
Intersecting/intersectional stigma: the convergence of multiple stigmatized identities due to 
intersecting prejudices related to affiliations to marginalized groups (e.g. migrants, ethnic or 
sexual minorities) or certain behaviours (substance use, sex work, etc)  
Stigma manifestations: the immediate results affecting how stigma is exhibited or experienced 
by individuals and groups and including anticipated, enacted and internalized stigma 
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Based on the “People Living with HIV Stigma Index” and stigma reports from more than 50 
countries,32,33 UNAIDS proposed that programming at all levels (legal and policy-, law 
enforcement-, institutional-, community- and individual level)31 should address HIV stigma.  
 
Consistent with intersectional stigma frameworks and acknowledging the multiple prejudices 
and stigmas experienced by many key populations living with HIV, the UK-based National 
AIDS Trust (NAT) concluded that the complex nature of HIV-associated stigma makes it 
“unlikely that any one-dimensional intervention will have a meaningful impact”.25 In line with 
UNAIDS, NAT recommended that governments design evidence-based interventions to reduce 
stigma at all levels through a comprehensive combination approach where all strategies are 
constructed with the following questions in mind: “Where (which setting/context?), What 
(needs to change?) and How (should this be done?)”25 
 
To date, there have been several helpful reviews of stigma reduction interventions to guide 
future work in this area. The availability of effective interventions to reduce HIV stigma was 
reviewed in 2011, but only two out of 19 selected publications included people living with HIV, 
and most were deemed to be of poor validity due to shortcomings in the study designs.34  A 
more complete review of current interventions on the stigmatization process published in 
201323 found that most studies only addressed one socio-ecological level or one single domain 
of stigma, and largely had focused on stigma drivers (individual level) and facilitators (societal 
level), while few studies included people living with HIV.23 More recently, in 2017, Mak et al. 
reviewed a broad array of HIV stigma interventions aimed to reduce negative attitudes towards 
people living with HIV35 and found small significant reductions by interventions targeting 
stigma at multiple levels: community members, healthcare workers, and students.35 Another 
recent review by Pantelic et al. on reduction of HIV self-stigma in low-and middle-income 
countries observed that structural-level interventions such as ART provision, economic 
strengthening and social empowerment, as well as cognitive behavioural therapy at individual 
level, lead to the most consistent self-stigma reductions.36 However, interventions aimed to 
improve health awareness, stigma coping and behavioural change appeared ineffective.36 
Lastly, in 2019, Rao and colleagues reviewed multi-level stigma reducing interventions for 
numerous stigmatizing conditions (HIV, mental health, leprosy, etc.) across a broad variety of 
populations and socio-ecological levels but did not analyze the effect on stigma experienced by 
people living with HIV themselves.37  
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While prior reviews have rarely focused on stigma experienced by people with HIV and 
HRQoL, it is clear most interventions conducted so far have used information-based 
approaches.23 Corrigan has argued that educational interventions alone rarely change attitudes, 
but mainly teach people to suppress their negative attitudes,38,39 and that health awareness 
campaigns have little effect on self-stigma, consistent with recent findings.36 To address this 
problem, individual-level interventions have incorporated personal contact as a mechanism to 
affect attitude change. Personal contact “humanizes” a person with a stigmatized condition and 
subsequently reduces individual-level manifestations of stigma, i.e. the immediate results of 
stigma on people living with HIV and their overall HRQoL.23, 37,40 
 
Views on which stigma reduction strategies to implement may differ between people living 
with HIV, who often prioritize wider-context stigma reduction interventions,40 and researchers 
and providers, who rank behavioural interventions higher.40 Further, people living with HIV 
can provide unique insight into their vulnerabilities and needs with respect to HIV-related 
stigma and HRQoL. Thus, for sustainable interventions to effectively reduce manifestations of 
stigma among people living with HIV, more interventions need to involve people living with 
HIV in the design, implementation and evaluation of intervention programs.28,41 Involving 
people living with HIV in  stigma reduction interventions may also help us reach the ”fourth 
90”.42  
 
Current Review  
We provide a narrative focused review of stigma reduction interventions that have implications 
for HRQoL for people living with HIV across all income settings. We focused on individual-
level interventions that target manifestations of stigma, i.e. the immediate effects of stigma on 
people living with HIV. We examined recent interventions that targeted enacted, anticipated, 
and internalized stigma among people living with HIV. The overarching goal was to increase 
our knowledge about which, and to what extent, current individual-level stigma reduction 
interventions have been effective. Furthermore, we set out to: 1) assess whether current 
programmes are designed in collaboration with people living with HIV; 2) identify gaps in 
targeting of certain key populations, settings or regions; and 3) provide recommendations to 
increase the coverage of effective interventions and fill any knowledge gaps for stigma 
reduction interventions with implication for HRQoL (see Box 2 for a description of search 
strategy and selection criteria used in the review process). A detailed description of the review 
process can be found in the Appendix (Table 1 and Table 2, page 2). 
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Box 2. Search Strategy and Selection Criteria 
 
The Impact of Interventions to Reduce Experienced HIV Stigma by Study Design  
Our search yielded 27 records46-72 representing various study designs in low-, middle-, and 
high-income settings (Table 1). The majority of studies were conducted in North America, Sub-
Saharan Africa and Asia. Importantly, there were no studies from North- or West Africa, South 
America, Australia and the Pacific region nor Europe.  
 
  
This narrative review begun as a systematic review in order to identify studies that fulfilled 
the following specific criteria:  
1) a study population including people living with HIV  
2) an intervention aimed to reduce HIV stigma and/or discrimination  
3) an assessment of the effect of the intervention in terms of reducing HIV-stigma affecting   
people living with HIV. 
 
We conducted a systematic search of five major databases: MEDLINE through PubMed, 
CINAHL, PsychINFO, Web of Science, and the Cochrane Library. A broad search strategy 
was used including combinations of keywords and/or MeSH terms for the three key terms 
“HIV”, “stigma” and “intervention”. We restricted our search to studies published between 
2010-2018, English language studies, and studies with an abstract and full text available. In 
addition to databases, we searched for relevant articles in the reference lists of identified 
systematic reviews.  
  
Risk of bias in included articles was assessed with validated quality assessment tools for each 
design; for randomized controlled trials (RCTs) and cluster randomized studies, we used the 
National Institutes of Health (NIH) tool Quality assessment of controlled randomized trials 43 
and studies with pre-post designs were assessed with the NIH tool Quality assessment tool for 
Before-After (Pre-Post) studies with no control group.44 Qualitative studies were assessed 
using a checklist designed and recommended by the Swedish Agency for Health Technology 
Assessment and Assessment of Social Services.45 A detailed search strategy and risk of bias 
assessment can be found in the Appendix.  
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Quasi-Experimental Approaches 
Among studies performing quasi-experimental designs, one study found that empowerment and 
educational radio programmes significantly reduced the stigma in groups of people living with 
HIV in Tamil Nadu, India.62 Another study in Ethiopia  evaluated a large-scale intervention 
over 7 years that included non-healthcare professionals who offered integrated home-based care 
and support for families and orphans, stigma reduction, and income generating activities at 
community level and found positive  changes in community attitudes toward people living with 
HIV and improved QoL among people living with HIV.65  
 
Qualitative or Mixed-Methods Approaches 
Intervention studies with qualitative designs indicated favourable intervention effects. Initial 
workshops for people living with HIV focused on understanding HIV stigma, personal strengths 
and disclosure management were often followed by workshops for partners, children and 
friends;55 peer support groups;60 or small support teams of neighbours, relatives, and friends 
(so-called “micro-clinics”) trained together to provide psychosocial and adherence support in 
countries such as Uganda60 and Kenya.69 One study that examined a patient-centred holistic 
care intervention among adults living with HIV in Kenya found that simple mechanisms for 
support, compassion and improved communication in routine care increased self-esteem, 
stigma resilience and increased confidence to disclose HIV status.58 
 
RCT and Pre- and Post-Test Approaches 
In studies with a quantitative design, perceived stigma was often assessed through self-
administered questionnaires to participants living with HIV. Many studies showed statistically 
significant reductions in perceived stigma across all participants, 47,50,54,57,64,67,70,71 while few 
found varying impact depending on gender56 or provider category.59  One study in the US found 
that the effect of a group-based behavioural intervention among youth on HIV awareness, 
coping skills and contact with other youth sustainably reduced stigma among young males 
across all four dimensions of stigma manifestations (personalized stigma, disclosure concerns, 
negative self-image and concern with public attitudes about people living with HIV), while 
young females only experienced a temporary decline in personalized stigma and increased 
stigma across the other three types of stigma manifestations.56 Moreover, another study found 
that a community support initiative in South Africa through ‘treatment buddies’ decreased the 
stigma experienced by people living with HIV, while stigma increased when a healthcare 
professional provided the support.59 Research in Uganda found mixed results in clients’ 
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experiences of enacted stigma at the healthcare facility level following a “creativity 
intervention” aimed at generating a more caring attitude between staff, peers and people living 
with HIV.63 Lastly, a study conducted in the US evaluated the potential stigma reducing impact 
of a patient-centred mental health program for under-served adults living with HIV based on 
active decision-making and individualized care plans including a range of therapeutic services 
following a comprehensive biopsychosocial assessment at enrolment. Although the evidence 
was rated as being of poor quality in our review, self-reported stigma appeared to decrease 
across the three dimensions in the HIV Stigma Scale: distancing, blaming and discrimination.54 
 
In contrast, several studies using either an RCT or a pre- and post-test design showed no 
statistically significant reductions in stigma among people living with HIV,46,48,51,61,68 although 
some authors said they observed important stigma reductions “in practice”52,66 or trends 
indicating stigma reduction.49 For example, one study described that stigma appeared to decline 
following a peer-led video and writing intervention among African-American women living 
with HIV.53 On a similar note, in Vietnam, a separate study found no reductions in stigma 
following peer-led support visits, but they did see improved QoL 12 months post intervention 
among patients with severely immunosuppressed condition.72 
 
Types of HIV-Related Stigma Interventions, Target Groups and Settings 
 
The majority of the included papers described interventions that targeted specific groups living 
with HIV such as women,47,53,64,67 children/families,49,56,60,70,71 ethnic subgroups51,53,67  or key 
populations such as adolescents49,56 and MSM,46,68 while only two included people living with 
HIV with other comorbidities, i.e. chronic pain58 or mental health issues.54 Some interventions 
were multi-level, including community members, social networks, family members/caregivers 
and healthcare workers.48,55,57,60,69,71 Most interventions were delivered by therapists or 
healthcare professionals and included individual or group sessions with people living with HIV, 
while some were peer-led or community-based. Table 1 describes the target groups, 
implementers and interventions in detail (Table 1).  
 
Approximately half of the included studies reported some involvement of people living with 
HIV. Among these studies, people living with HIV were described as being involved in various 
stages of the intervention design,49 the intervention implementation (i.e. as peer-educators) 
48,52,55,56,59,66,69 or both. 51,53,60,62,67,72    
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About half of the included studies broadly mentioned the relationship between stigma and QoL 
in the introduction or  discussion section, but few studies assessed the impact of the intervention 
on both stigma and HRQoL.50,65,72 These studies found that QoL improved after the stigma 
reducing interventions. 
 
Knowledge Gaps 
The majority of the stigma and discrimination reducing interventions that have been evaluated 
were quantitative in nature, with only two mixed-methods studies and four qualitative studies. 
All interventions relied to some extent on participants’ ability and willingness to express 
themselves verbally, most often in groups. This may not be the most suitable model for 
individuals who do not have the capacity or who do not feel comfortable speaking about 
themselves and their HIV infection in front of others. Teti et al.73, although not fulfilling the 
quality requirements of this review, provided an interesting alternative to group sessions by 
encouraging individual artistic expressions to reduce personalized stigma.73 
 
None of the intervention studies included in this review were conducted in north- or west Africa, 
South America, Australia or the Pacific region nor Europe, despite these regions being home to 
over a third of all people living with HIV globally.74 Additionally, settings where the three 90s 
are largely fulfilled, and with a rapidly growing population who are ageing with HIV, such as 
western Europe and Australia, were not represented in the literature at all, marking a serious 
knowledge gap on progress towards HRQoL and the “fourth 90”.  
 
This review also found an absence of intervention studies on HIV stigma and discrimination in 
non-HIV specific healthcare settings, e.g. clinical settings that treat common co-morbidities 
including care for older people living with HIV, a group with a greater need for healthcare 
services that go beyond ART.  
 
Furthermore, to date, no published stigma reducing interventions have been evaluated among 
several important key populations at elevated risk of HIV infection, for example migrants, 
transgender persons and prisoners, and very few studies focused on people who inject drugs, 
sex workers, MSM, adolescents and young people. Racial or ethnic subgroups were rarely 
considered outside of North America. Lastly, more interventions should document any 
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involvement of people living with HIV in the study design or in other stages of the 
interventions, since such interventions have often been found to be most effective.  
 
While the effects of stigma reducing interventions may have implications on QoL, very few 
studies explicitly assessed the impact of the intervention on both stigma and HRQoL.50,65,72 
 None of the included interventions specifically targeted intersectional stigma or assessed the 
effect of the stigma reducing interventions on intersectional stigma commonly experienced by 
many marginalized populations disproportionally affected by HIV infection. 
 
Conclusions  
Our review identified a lack of well-designed intervention studies that document stigma 
reduction. Of the 27 studies that met our inclusion criteria, only three specifically assessed the 
impact of HIV stigma on HRQoL, despite knowledge of overall HRQoL being directly related 
to experiences of stigma among people living with HIV. Further, few interventions explicitly 
described the inclusion of people living with HIV in both their intervention design and 
implementation. Lastly, our review highlights a lack of evidence on effective HIV stigma 
interventions in several large geographic regions and among several key populations.  
Further research is warranted on intersectional stigma as well as ways to reduce HIV stigma 
and discrimination beyond the HIV-specific healthcare setting for people ageing with HIV and 
people with comorbidities and mental illness, a priority in the strive towards improved HRQoL 
among people living with HIV. The application of cross-cutting theoretical frameworks for 
research and interventions to reduce health-related stigma across multiple stigmatized health 
conditions should also be further explored in the context of HIV.28,29  Reducing stigma and 
improving HRQoL are imperative for reaching the “fourth 90” and Sustainable Development 
Goals 3 and 10 (good health and wellbeing for all and reduced inequalities through decreased 
vulnerability, marginalization and discrimination),75  as well as achieving more equitable health 
at the global level. 
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Box 3. Recommendations for Future Policy and Research 
 HRQoL measures need to be consistently included in HIV-related stigma 
interventions.  
 Meaningful inclusion of people living with HIV in the design, development, 
implementation and interpretation of stigma reducing interventions is required if 
interventions are to be effective.  
 More evidence is needed to address stigma among older people living and ageing 
with HIV, including those with comorbidities who are seeking services additional to 
their HIV specific care.   
 Future evaluations of the efficacy of new policies and stigma interventions among 
neglected sub- and key populations, including those facing intersecting stigma, are 
needed.  
 The absence of contextual evidence required to design effective stigma reducing 
interventions for people living with HIV in north- or West Africa, South America, 
Australia and the Pacific region and Europe, should be addressed through additional 
research. 
 Interventions must be contextualized to the setting and sub-population, and tailored 
to account for variation in verbal ability and willingness to participate in group 
sessions, which may vary between different sub-groups and individuals living with 
HIV. 
 Innovation in civil society involvement that addresses HIV stigma beyond 
traditional peer-support programs and healthcare settings is required.  This must be 
adequately resourced to enable effective and rigorous evaluation that can then 
enable sharing of best practice. 
 Future research must take a combination approach that looks at HIV associated 
stigma through a multi-level (individual, structural, etc.) and intersectional lens, 
ideally using existing validated tools and frameworks to enable cross study 
comparisons. 
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